#3 Cocoa + Natto - E-book
The email
Hey Michael,
Talk soon,
Antonio
CEO, Black Forest Supplements
You are receiving this because you subscribed. Unsubscribe.
Internal notes · Final · #3 CocoaNatto - E-booklinks, deliverability, the lines to rule on
Klaviyo campaign name: #3 CocoaNatto - E-book. Final copy from Juan, Nov 2, built verbatim. 312 words across the two body images; no P.S. Mobile: image 1 · image 2.
Links: image 1 (SEE) TBD; image 2 → https://blackforestsupplements.com/pages/be-first. The earlier build tagged this link ?src=cn-03-early so the 04b audience can be read by URL; without the tag, build that segment on “clicked this campaign” instead.
Deliverability (GlockApps corpus, 648 valid seed runs, read Nov 2): “You should know this,” 34 runs, best pairs ~89-90% inbox; “Read this,” 3 runs, 88.5% (with “I wasn’t planning to send this today.”). Neither has been seed-tested with a bare “Hey {first_name},” wrapper.
Canon gates on this text (reported, not rewritten):
- clot overclaim (1×): “Japan solved it at breakfast” states an outcome from an association (E11 is observational). Blog 04 says the opposite: “A bowl of soybeans doesn’t explain all of that.”
“…. Your checkup has never once looked at it. Japan solved it at breakfast a thousand years ago. In 1987 a Japa…” - names it before #4 (4×): Japan, the 1987 researcher and the 173 foods are named three days before the reveal (canon kept them for 04). Your call; the e-book chapter 4 tells the same story.
“…ur checkup has never once looked at it. Japan solved it at breakfast a thousand years…” - “After 50 it comes off slower than it goes on”: no primary on file. Fibrinolysis does slow with age, but the age 50 and the rate need a source, or the line softens to “With age”.
- “the list closes that same day”: true only if the 04b segment is frozen at 04b’s send, as planned.
The texts
A · Antonio’s
29 words, verbatim from the soap opera v3. Link: early access page, src=cn-03-sms.
Rating · A · Antonio’sA 7.0 · 8.0 · 7.0 · 5.0 · 4 (comparable)
| Criterion | Score | Why |
|---|---|---|
| 1 · Soap Opera Sequence | 7.0/10 | Hype beat: names the list and opens it. |
| 2 · Hook / Story / Offer | 8.0/10 | “8 signs” plus “the dose trick on the back of every natto bottle”: a strong curiosity hook; clear offer. |
| 3 · The 3 Closes | 7.0/10 | Curiosity and a deadline; no logic close (fine for a text). |
| 4 · BFS SMS house style | 5.0/10 | No ‘Hey’ fallback on the first name; no “we” voice; names natto before #4; “closes Friday” contradicts the email (“the list closes the same day it opens”). |
| 5 · Antonio’s RPR scale | 4.0/10 | Comparable only: BSO #4 text, $0.06. |
Criterion 5 in Antonio’s format
Comparable, not a measurement (unsent). Closest shipped text: [SMS] #4 Black Seed Oil - Parasite Video (Jul 30), live pull Oct 29: $0.06 RPR, 0.12% CVR, $3,051 on 50,206 sends → 4/10.
Keeping it from a 10: 1. add the fallback; 2. drop “natto” (“every bottle” works); 3. drop “closes Friday” or make it true.
B · ours
35 words, house style (first name with ‘Hey’ fallback, “we” voice, 👇 before the link). Link: src=cn-03-sms.
Rating · B · oursB 7.0 · 7.0 · 6.5 · 8.5 · 4 (comparable)
| Criterion | Score | Why |
|---|---|---|
| 1 · Soap Opera Sequence | 7.0/10 | Hype beat; opens the list. |
| 2 · Hook / Story / Offer | 7.0/10 | “7 signs” is a good hook; no curiosity beat about the bottle; clear, honest offer. |
| 3 · The 3 Closes | 6.5/10 | “Nothing to buy” lowers the bar; no deadline. |
| 4 · BFS SMS house style | 8.5/10 | Fallback, “we” voice, 🚨 and 👇, 35 words, names nothing. |
| 5 · Antonio’s RPR scale | 4.0/10 | Comparable only: BSO #4 text, $0.06. |
Criterion 5 in Antonio’s format
Comparable, not a measurement (unsent). Closest shipped text: [SMS] #4 Black Seed Oil - Parasite Video (Jul 30), live pull Oct 29: $0.06 RPR, 0.12% CVR, $3,051 on 50,206 sends → 4/10.
Keeping it from a 10: 1. borrow A’s bottle hook (“and the dose trick on the back of every bottle”); 2. say when the list closes, truthfully.
The e-book outline11 chapters, the beat and the source behind each
Working title: The Two Places
The value asset: the e-book (outline, Oct 29). Both SEE buttons open it; chapter 1 is the label survey the button promises. Cover kept (cover →). PDF on the Shopify CDN. Chapters written after this outline is approved.
| Act | What it does, and what binds it |
|---|---|
| 0 · Foreword | Hook. The three-year study at 2,000 FU that found nothing (Hodis 2021), the one people quote to say it doesn’t work. It tested one amount, in low-risk people. No line borrowed from the Cardiac Codex. E24. About 400 words, one page. |
| 1 · The Dose on the Back of the Bottle | What the SEE button promises. The bestselling US nattokinase bottles, each label’s FU per serving read and dated, next to what the studies used. Bottles named only if counsel clears it; otherwise “Bestseller #1…#N” with the label text. To RUN: Amazon + iHerb top sellers, label reads dated. No number prints before it is read. |
| 2 · Two Places, One Checkup | Expose. Slot 01’s thesis: the number that reads “optimal”, and the two places a checkup never measures. Slot 01 canon. |
| 3 · The First Place: The Wall | Expose. Blog 02 condensed: Furchgott, the signal that fades with age, the Kuna, the studies that blocked the signal. E29, E33-E38; Mars ties disclosed. |
| 4 · The Second Place: What Forms Inside | Callback, not a reveal. How a clot forms and how the body breaks it down, as plain physiology. “In May I told you about Dr. Sumi. Here’s what I left out.” E9; a physiology primary read first. Never “fibrin causes plaque”. |
| 5 · The Amount Nobody Questioned | Equip. Hodis (2,000 FU, 3 years, no change), Kim 2008 (2,000 FU, 8 weeks, −5.55 / −2.84 mmHg), Kurosawa 2015 (one dose, markers up within hours, all in the normal range), Chen 2022, which its own authors say was not randomized, made with the tablet maker. Asked, not answered: what if the trials tested too little? E6, E24-E26. Our amount withheld for #4; no %. |
| 6 · The Cocoa Question | Equip. Alkali processing strips the flavanols; labels that hide the amount; heavy metals; COSMOS with its main result stated as not significant. A label checklist our cocoa passes. E3, E5 (re-read the Consumer Reports report first), E39. Supplier never named. |
| 7 · Signs Worth Raising With Your Doctor | Prime. The NHS’s early signs of poor blood flow to the legs, and what to ask. Not the Codex’s four tests. NHS PAD page (reviewed 10 Apr 2026). Never tied to the formula. |
| 8 · Before You Add Anything | Safety. Anyone on anticoagulant or antiplatelet medication, with a bleeding disorder, or with surgery coming up talks to their doctor first. Counsel’s wording. |
| 9 · What We’re Building | Tease + ask. The early access list. No name, no dose, no preparation line. Links to https://blackforestsupplements.com/pages/be-first?src=cn-03-early. |
| 10 · References | Every study with its link; Mars ties and the Chen manufacturer disclosed. All E-numbers above. |
Statusfinal email copy Nov 2; the SEE link, the e-book, counsel, Klaviyo build, GlockApps and scheduling to come
The send, and what it exploresthe list + early access: the second place, the signs to tell your doctor about, PUT MY NAME DOWN; no e-book
Subject (final, A/B): “You should know this, {first_name}! / Read this, {first_name}!”
Antonio’s review rated this beat 9.0; the rating is a judgement, not a measurement. Epiphany plus the hype build in one send: it closes slot 02’s promise (“a second discovery behind the new formula”) with the second place, gives the reader a list to recognise himself in, and opens the early access list that 04b and 06 pay off. Two CTAs, both free: SEE (the e-book) and PUT MY NAME DOWN.
Claims, per the review: the list goes to the doctor, not the formula; clotting is told as normal physiology, never as the cause of plaque; the dose point is a question about the trials (“a fraction of the amount we chose”), never “you took a fifth and called it a failure”. The email: Juan’s final (Nov 2), built from Antonio’s version; two body images, the SEE link still TBD. Format evidence, checked Oct 29 against the launch history (Klaviyo pull Sep 2): neither format has a measured edge on our list. E-books ran in five arcs: NMN $0.255, Serious Creatine $0.212, BSO $0.137, natto $0.091, coffee $0.076, about level with each arc’s own value-send average (above it in two, below in two, level in one). The BSO list email this slot copies (#4, Jul 30) was that arc’s weakest value send ($0.120, 0.72% CTR). The BSO qualifier ($0.316) went to the full list (199,295), not to the hand-raisers, so no number shows the early access list feeding it. The soap opera v3 claim that e-books were the weakest send in every arc is false.
The precedent, as shippedthe BSO list email, beat for beat
#3 Black Seed Oil - Blog (Jul 30 2026, 194,536 recipients, 42.7% open, 0.72% click): “Last Friday I gave you the name… Before I show you what we built, I owe you something more useful. The list.” Eight symptoms; “Read it again, and notice what it shares”; “I am not saying parasites cause everything you feel”; SEE THE TESTING PROBLEM AND THE LAB RESULTS; “That became our standard”; “When it opens, the founding group sees it first, and the list closes that same day”; PUT MY NAME DOWN (EARLY ACCESS LIST); “Nothing to buy today. This only decides who goes first.”
Research brief & gatesevery figure, its source, and the lines it may not cross
Email names nothing (gated). Must not say the product, its name, any dose, price or offer, scoop, jar, the combination, synergy, heat or coffee.
- The list: NHS PAD page, early symptoms, reviewed 10 Apr 2026 (source). Counsel reads it: a symptom list a week before a launch must never read as the product’s job.
- Sumi 1987 (E9): 173 foods, written as a callback (“you may remember”) because the Cardiac Codex told it in May.
- Hodis 2021 (E24): 2,000 FU, 3 years, null in low-risk adults. “A fraction of the amount we chose” is true; no number prints.
- Gated out (Antonio’s review): the felt-benefit ladder, dose-shaming, “reverse”, “clears plaque”, “dissolves”, drug names.
The early access list: what Juan buildshow the list is captured and used
PUT MY NAME DOWN → https://blackforestsupplements.com/pages/be-first?src=cn-03-early (the be-first page; phone optional there). The 04b audience = profiles who clicked that link in this campaign (Klaviyo segment: Clicked Email, URL contains cn-03-early) + cocoa buyers. “The list closes that same day” = the segment is frozen at 04b’s send.
The value asset: the e-book, not a blogwhy no blog, and the precedent
No blog. The value asset is the e-book (Juan, Oct 29: keep the list email’s concept, not its value send). Both SEE buttons open the e-book; its first chapter is “The Dose on the Back of the Bottle”, so the button delivers what it says.
The blog precedent, checked: there isn’t one. The BSO list email this slot copies (#4, Jul 30) linked to a video landing page (its text: “80 million Americans carry a parasite… See why” → neglected.blackforestsupplements.com), not a blog. A blog here would make 01, 02, 03 and 04 four blog-style sends in a row. Every launch since Sep 2025 that ran an e-book used it to break that run (NMN, Serious Creatine, natto, BSO, Protein Coffee).
Built the way the e-books that paid were built (NMN $0.255, Serious Creatine $0.212): cover, five bulleted promises, a PDF on the Shopify CDN, never a Drive link (the natto Codex, $0.091). It must not repeat the Codex: no 173-foods reveal, no four tests, no “missing piece” spec.